ClinicalTrials.gg
RecruitingNCT07779967ABC-MetUpdated Sep 8, 2026

Alcohol, Breast Cancer, and Metabolism

An interventional study of Low-alcohol level exposure and Breast-pumping time in Alcohol Drinking, Ethanol Intoxication and Breastfeeding, sponsored by University of Illinois at Urbana-Champaign. Recruiting at 1 site in United States. Open to female participants aged 21 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-08.

Primary conditionBreast FeedingRegistry: Alcohol DrinkingReclassifiedWhy we changed it
Registry
Alcohol Drinking — the first condition term the registry derived for this study.
ClinicalTrials.gg
Breast Feeding
Why
  1. Alcohol Drinking is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Breast Feeding.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Illinois at Urbana-Champaign · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
21 Years to 45 Years
Sex
Female
01

Study summary

Alcohol consumption, even at low levels, has been associated with increased breast cancer risk, but the biological mechanisms underlying this relationship remain unclear. This study will examine whether breast tissue may locally metabolize alcohol by measuring alcohol-related compounds in paired blood and breast milk samples from lactating women. The findings may help clarify alcohol-related biological pathways relevant to breast cancer risk and improve risk communication.

Read the detailed description

Alcohol consumption has been associated with an increased risk of female breast cancer, including at low levels of intake. The biological mechanisms underlying this association are not fully understood. One proposed pathway involves the metabolism of alcohol to alcohol-related compounds that may affect tissue biology.

This study will examine alcohol metabolism in lactating women using paired blood and breast milk samples collected after low-level alcohol exposure. Human milk provides a non-invasive way to study biological processes occurring in the breast during lactation. By comparing alcohol-related measurements in milk and blood, and by considering the timing of sample collection relative to alcohol intake and breast pumping, the study will evaluate whether breast milk measurements provide information about local alcohol metabolism in the mammary gland that may not be reflected by blood measurements alone.

The goal of this research is to improve understanding of how low-level alcohol exposure may influence biological pathways relevant to breast cancer risk. Findings from this study may help inform future research and support clearer risk communication regarding alcohol consumption and breast health.

02

Conditions studied

  • Alcohol Drinking
  • Ethanol Intoxication
  • Breastfeeding

Browse trials for

Keywords

  • lactating
  • women
  • alcohol
  • ethanol
  • metabolism
  • breastmilk
03

In context

Breast Feeding Reclassified

1,081 studies on the registry are indexed under Breast Feeding; 217 are open to participants now.

This study's planned enrollment of 50 is below the median of 100 across 844 interventional studies indexed under Breast Feeding.

Browse Breast Feeding studies →

Lead sponsor

University of Illinois at Urbana-Champaign is the lead sponsor of 191 studies on the registry; 29 are open to participants now.

Compared within Breast Feeding, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Alcohol Drinking. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
21 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

All aims

-Drink alcohol (at least one alcoholic drink during lactation of a lactating female)

For aims 1 and 2

  • Nursing a 2- to 5-month-old infant
  • Experienced with a breast pump

Exclusion criteria

Exclusion Criteria:

  • Pregnant
  • Lifetime history of alcohol dependence
  • Drink more than 3 standard drinks per day or more than 7 standard drinks per week in the month previous to enrollment
  • Current regular use of drugs with addiction potential (other than alcohol)
  • Use of medications known to interact with alcohol metabolism
  • Current smoking
  • Anemia
  • Diabetes
  • Liver disease
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Arm 1: lactating women dose response

    Lactating women who will drink \~0, 1 or 2 standard drinks of alcohol

    Other: Low-alcohol level exposure

  • Experimental
    Arm 2: timing of pumping

    Lactating women will pump at two different times from alcohol drinking and at one of these times after placebo drinking

    Other: Breast-pumping time

  • Other
    Aim 3: non-lactating control women

    Non-lactating women of similar age, BMI, and alcohol consumption characteristics will drink a similar dose of alcohol as lactating women for the assessment of systemic alcohol-related measurements. This group will serve as a comparison group for interpreting alcohol-related measurements in lactating participants.

    Other: Low-alcohol level exposure

Interventions

  • OtherLow-alcohol level exposure

    Participants will consume a protocol-specified low-level alcohol exposure under study conditions. The assigned dose and biospecimen collection procedures will vary by study group.

  • OtherBreast-pumping time

    Breast pumping before or after drinking \~ 1 standard drink or placebo drink

06

What researchers measure

Primary outcomes

  1. Blood alcohol concentrations

    Alcohol concentrations in blood

    Time frame: 2- 3 weeks

  2. Milk alcohol concentration

    Concentration of alcohol in breast milk

    Time frame: 2- 3 weeks

  3. Milk acetaldehyde

    Concentration of acetaldehyde in human milk

    Time frame: 1-3 weeks

  4. Blood acetaldehyde

    Concentration of acetaldehyde in blood

    Time frame: 1- 3 weeks

07

Study locations

1 of 1 sites recruiting
  • Bevier Hall; University of Illinois at Urbana Champaign
    Urbana, Illinois 61801, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — De-identified participant demographic and screening variables (e.g., age, BMI, lactation characteristics) Alcohol dosing information based on measured fat-free mass Time-resolved physiological and pharmacokinetic data (e.g., blood alcohol concentration, breath alcohol concentration, elimination rates, AUC) Quantitative biochemical measurements of ethanol and acetaldehyde concentrations in paired human milk and blood samples obtained using headspace gas chromatography with flame ionization detection (HS-GC-FID) Derived variables generated for statistical and pharmacokinetic analyses

Supporting information: Study protocol, Informed consent form

Time frame: From the end of the grant until NIAAA Da allows it.

Access criteria: The data will be shared with NIAAA DA and they will determine the protocol to access.

Data sharing details ↗ · www.niaaa.nih.gov

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Jul 2031, 58 months later.

Of 502 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 58 months is above that.

Counting every sponsor, half of 510 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 18, 2026
First posted
Aug 21, 2026
StartEst.
Sep 3, 2026
Primary completionEst.
Jul 13, 2031
CompletionEst.
Mar 1, 2032
Last update
Sep 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07779967
Responsible party
Sponsor
First posted
Aug 21, 2026
Start date
Sep 3, 2026 (estimated)
Primary completion
Jul 13, 2031 (estimated)
Completion
Mar 1, 2032 (estimated)
Last update
Sep 8, 2026

Study contacts

Marta Y Pepino de Gruev, Ph D
Contact
ypepino@illinois.edu
217-300-2374
Marta Y Pepino de Gruev
principal investigator · University of Illinois at Urbana-Champaign

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion